U.S. FDA approves bluebird bio's gene therapy for a rare neurological disorder

日本 ニュース ニュース

U.S. FDA approves bluebird bio's gene therapy for a rare neurological disorder
日本 最新ニュース,日本 見出し
  • 📰 Reuters
  • ⏱ Reading Time:
  • 60 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 27%
  • Publisher: 97%

The U.S. Food and Drug Administration (FDA) has approved Bluebird bio's gene therapy for the treatment of a rare neurological disorder, the company said late on Friday.

Signage is seen outside of the Food and Drug Administration headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photogene therapy for the treatment of a rare neurological disorder, the company said late on Friday.

"SKYSONA is the first FDA approved therapy shown to slow the progression of neurologic dysfunction in boys" with early, active Cerebral Adrenoleukodystrophy , the company said in a statement, saying CALD is a "devastating and fatal neurodegenerative disease." Bluebird said it anticipates commercial product will be available by the end of 2022 through a limited number of qualified treatment centers in the United States.In August, the company's beti-cel therapy secured FDA approval to treat a rare blood disorder that was priced at a record $2.8 million, the most expensive treatment to date.CALD is caused by mutations in a gene called ABCD1 that leads to the buildup of very long-chain fatty acids in the brain and spinal cord.

Eli-cel adds functional copies of the ABCD1 gene in a patient's stem cells to help produce a protein required to break down the long-chain fatty acids. The approval was largely expected after the drug received unanimous endorsement from a panel of outside advisers to the FDA in June.Reporting by Mrinalika Roy and Jaiveer Shekhawat in Bengaluru; Editing by Sriraj Kalluvila, Devika Syamnath and William Mallard

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

Reuters /  🏆 2. in US

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

UW Medicine seeks participants for trial of drug to treat monkeypoxUW Medicine seeks participants for trial of drug to treat monkeypoxThe drug, tecovirimat, has already been approved by the U.S. Food and Drug Administration to treat smallpox.
続きを読む »

UN warns up to 345 million people marching toward starvationUN warns up to 345 million people marching toward starvationThe U.N. food chief warned Thursday that the world is facing “a global emergency of unprecedented magnitude,” with up to 345 million people marching toward starvation — and 70 million pushed closer to starvation by the war in Ukraine. David Beasley, executive director of the U.N. World Food Program, told the U.N. Security Council that the 345 million people facing acute food insecurity in the 82 countries where the agency operates is 2½ times the number of acutely food insecure people before the COVID-19 pandemic hit in 2020.
続きを読む »

Feeling skimpy: Food industry waters down quality, services as costs riseFeeling skimpy: Food industry waters down quality, services as costs riseA saltwater-infused “frozen dairy dessert” that’s billed as an ice cream substitute. Cans of ham that are 35% water. Smaller tubs of coffee beans that claim to make the same number of cups as larger tubs.
続きを読む »

Food Truck Owner’s ‘Cult-Like’ Group Laid Bare by Ex-MembersFood Truck Owner’s ‘Cult-Like’ Group Laid Bare by Ex-MembersMore ex-members and family members are speaking out against Bad Rooster owner Soulaire Allerai and her “cult-like” group: “I realized that I would rather die than keep going there.”
続きを読む »

Here’s why food prices are so high and what you can do about itHere’s why food prices are so high and what you can do about itAmericans may be getting some relief at the gas pump, but they are not finding that relief at the grocery store.
続きを読む »



Render Time: 2025-03-10 01:59:01